Option Care Health, Inc.  closed at $31.00 on October 7, 2026, rising $7.63, or 32.65%, in a sharp advance that lifted the healthcare company’s intraday market capitalization to approximately $4.64 billion. The stock’s five-day performance reached approximately 35.91%, while pre-market trading showed shares unchanged at $31.00.

Option Care Health Stock Performance

Option Care Health opened at $31.04 and traded between $30.97 and $31.11 during the session before closing at $31.00. The previous close was $23.37, highlighting the scale of the latest advance.

Trading volume reached approximately 65.08 million shares, dramatically above the average volume of approximately 3.18 million shares. The surge in volume accompanied the stock’s sharp price increase.

Option Care Health has a 52-week trading range of $18.01 to $36.80. The stock’s trailing P/E ratio stands at 23.48, while trailing EPS is $1.32. Its five-year monthly beta is 0.58, indicating relatively lower historical volatility compared with the broader market.

Home and Alternate Site Infusion Services

Option Care Health provides home and alternate site infusion services across the United States. Its services cover a broad range of medical needs, including anti-infective therapy, home infusion services and parenteral and enteral nutrition support.

The company also provides immunoglobulin infusion therapies for immune deficiencies and treatments for chronic inflammatory conditions. These include therapies addressing Crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis and other chronic inflammatory disorders.

Broad Specialty Healthcare Services

Option Care Health also provides treatments designed to manage the progression of neurological disorders, including Duchenne muscular dystrophy, multiple sclerosis and Alzheimer’s disease.

Its infusion portfolio extends to bleeding disorders such as hemophilia and von Willebrand disease, as well as therapies for women experiencing high-risk pregnancies.

Additional infusion services include treatments for pain management, chemotherapy and respiratory medications, alongside nursing services.

Patient Referral Network and Leadership

The company markets its services through patient referrals from physicians, hospital discharge planners, hospital personnel, health maintenance organizations and preferred provider organizations.

Option Care Health is headquartered in Bannockburn, Illinois, and employs approximately 8,000 full-time employees.

The company is led by John Charles Rademacher, who serves as CEO, president and director. Other executives include Executive Vice President and CFO Meenal Anil Sethna, Chief Operating Officer Luke Whitworth, General Counsel and Corporate Secretary Collin G. Smyser, and senior executives responsible for technology, compliance, strategy and corporate development.

Market Context & Opportunities

Option Care Health’s broad infusion-services platform gives the company exposure to multiple areas of specialty healthcare, including immune deficiencies, chronic inflammatory diseases, neurological disorders and complex therapies administered outside traditional hospital settings.

The company’s large network of healthcare referrals and approximately 8,000 employees provides an established operating base within the U.S. infusion-care market.

The latest market data also shows significant investor activity, with volume exceeding 65 million shares compared with a typical daily average of approximately 3.18 million shares.

However, the supplied market information does not identify a specific catalyst behind the 32.65% October 7 advance. The price movement therefore should not be attributed to a particular announcement without additional evidence.

Risks & Challenges

The sharp increase in Option Care Health shares brings the stock closer to its 52-week high of $36.80. After a five-day gain of approximately 35.91%, investors may face increased volatility as the market assesses whether the recent momentum can be sustained.

The company also operates in a complex healthcare environment where patient demand, reimbursement conditions, regulatory requirements and the costs associated with specialized therapies can affect financial performance.

The upcoming earnings report will provide an important opportunity for investors to evaluate the company’s operating trends following the recent stock-price surge.

Upcoming Earnings

Option Care Health is scheduled to report earnings on November 4, 2026, according to the provided market data. Investors will likely focus on the company’s financial performance, demand for infusion services and outlook as the stock trades near the upper portion of its 52-week range.

Closing Paragraph

Option Care Health closed at $31.00 on October 7, up 32.65%, with trading volume exceeding its average by more than 20 times. With approximately $4.64 billion in market capitalization, a broad portfolio of home and alternate site infusion services and exposure to multiple specialty healthcare categories, Option Care Health remains a closely watched healthcare stock heading into its November earnings report.